IART - Integra LifeSciences Holdings Corporation
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $0.79
|
Rev Est: $429.6M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$15.00
DETAILS
HIGH:
$15.00
LOW:
$15.00
MEDIAN:
$15.00
CONSENSUS:
$15.00
UPSIDE:
30.10%
Market Cap:
898.10M
Volume:
519,267
Avg Volume:
734,023
52 Week Range:
10.6-25.45
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
1.03
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
4,396
IPO Date:
1995-08-16
EPS (TTM):
-0.09
P/E Ratio:
-251.52
Revenue (TTM):
1.61B
Total Assets:
4.04B
Total Debt:
1.98B
Cash & Equiv:
246.38M
Rev Growth (5Y):
1.2%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
-23.7%
ROCE:
1.7%
Debt/Equity:
1.28
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-10-30 | $0.54 | $0.43 | +25.6% | $402.1M | $429.6M | -6.4% |
| 2025-07-31 | $0.45 | $0.43 | +4.7% | $415.6M | $414.3M | +0.3% |
| 2025-05-05 | $0.41 | $0.43 | -4.7% | $382.7M | $402.6M | -4.9% |
| 2025-02-25 | $0.97 | $0.86 | +12.8% | $442.6M | $411.7M | +7.5% |
| 2024-11-04 | $0.41 | $0.39 | +5.1% | $380.8M | $445.5M | -14.5% |
| 2024-07-29 | $0.63 | $0.62 | +1.6% | $418.2M | $413.1M | +1.2% |
| 2024-05-06 | $0.55 | $0.55 | 0.0% | $368.9M | $362.0M | +1.9% |
| 2024-02-28 | $0.89 | $0.90 | -1.1% | $397.0M | $399.3M | -0.6% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.61B | 1.54B | 1.56B | 1.54B | 1.37B | 1.52B | 1.47B | 1.19B | 992.08M | 882.73M | 928.30M | 836.21M |
| Net Income | (6.94M) | 67.74M | 180.55M | 169.07M | 133.89M | 50.20M | 60.80M | 64.74M | 74.56M | (3.52M) | 34.00M | (16.98M) |
| EPS | -0.09 | 0.87 | 2.18 | 2.00 | 1.58 | 0.59 | 0.73 | 0.83 | 1.00 | -0.05 | 0.52 | -0.30 |
| Total Assets | 4.04B | 3.78B | 3.89B | 3.78B | 3.62B | 3.30B | 3.11B | 3.21B | 1.81B | 1.77B | 1.58B | 1.20B |
| Total Debt | 1.98B | 1.68B | 1.63B | 1.67B | 1.66B | 1.46B | 1.35B | 1.84B | 665.00M | 714.97M | 630.00M | 392.06M |
| Cash & Equivalents | 246.38M | 276.40M | 456.66M | 513.45M | 470.17M | 198.91M | 138.84M | 174.94M | 102.06M | 48.13M | 71.99M | 120.61M |
| Operating Cash Flow | 129.38M | 139.96M | 264.47M | 312.43M | 203.83M | 231.43M | 199.68M | 114.54M | 116.41M | 94.48M | 79.46M | 53.27M |
| Free Cash Flow | 24.96M | 73.09M | 217.38M | 264.35M | 139.94M | 96.90M | 121.94M | 71.04M | 69.08M | 61.07M | 37.07M | 5.42M |
| FCF per Share | 0.32 | 0.94 | 2.62 | 3.12 | 1.65 | 1.13 | 1.47 | 0.91 | 0.92 | 0.83 | 0.57 | 0.10 |
| Book Value | 1.55B | 1.59B | 1.80B | 1.68B | 1.51B | 1.42B | 1.38B | 962.31M | 839.67M | 751.44M | 704.32M | 670.18M |
| Cash & ST Investments | 273.57M | 309.10M | 456.66M | 513.45M | 470.17M | 198.91M | 138.84M | 174.94M | 102.06M | 48.13M | 71.99M | 120.61M |
| ROC Equity | -0.00 | 0.04 | 0.10 | 0.10 | 0.09 | 0.04 | 0.04 | 0.07 | 0.09 | -0.00 | 0.05 | -0.03 |